SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193805-23-001527
Filing Date
2023-11-22
Accepted
2023-11-22 16:20:46
Documents
7

Document Format Files

Seq Description Document Type Size
1 e619076_s3-immunic.htm S-3 274444
2 e619076_ex4-1.htm EX-4.1 317376
3 e619076_ex5-1.htm EX-5.1 21634
4 e619076_ex23-1.htm EX-23.1 1902
5 e619076_ex107.htm EX-FILING FEES 50635
6 GRAPHIC image_001.jpg GRAPHIC 5865
7 GRAPHIC image_002.jpg GRAPHIC 28754
  Complete submission text file 0001193805-23-001527.txt   715024
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275717 | Film No.: 231433756
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences